Entreprise · 18/03/20151 min de lecture
Cardiovascular and Renal Drugs Advisory Committee; Amendment of Notice
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Cardiovascular and Renal Drugs Advisory Committee. This meeting was announced in the Federal Register of February 27, 2015 (80 FR 10700). The amendment is being made to reflect a change in the Agenda portion of the document. There are no other changes.